vs
Mirion Technologies, Inc.(MIR)与Quantum-Si Inc(QSI)财务数据对比。点击上方公司名可切换其他公司
Mirion Technologies, Inc.的季度营收约是Quantum-Si Inc的615.1倍($277.4M vs $451.0K)。Mirion Technologies, Inc.净利率更高(6.2% vs -3904.9%,领先3911.1%)。Mirion Technologies, Inc.同比增速更快(9.1% vs -62.2%)。Mirion Technologies, Inc.自由现金流更多($63.2M vs $-16.4M)。过去两年Mirion Technologies, Inc.的营收复合增速更高(20.0% vs -0.7%)
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商,核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件,服务核电、医疗、国防、工业等多个核心领域,客户遍布北美、欧洲及亚太地区。
硅量子计算私人有限公司(SQC)是一家总部位于澳大利亚悉尼的量子计算领域企业,专注于量子计算相关技术的研发与商业化推进,是量子计算行业深耕前沿技术开发的代表性企业之一。
MIR vs QSI — 直观对比
营收规模更大
MIR
是对方的615.1倍
$451.0K
营收增速更快
MIR
高出71.2%
-62.2%
净利率更高
MIR
高出3911.1%
-3904.9%
自由现金流更多
MIR
多$79.6M
$-16.4M
两年增速更快
MIR
近两年复合增速
-0.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $277.4M | $451.0K |
| 净利润 | $17.3M | $-17.6M |
| 毛利率 | 48.8% | 27.1% |
| 营业利润率 | 9.2% | -4677.2% |
| 净利率 | 6.2% | -3904.9% |
| 营收同比 | 9.1% | -62.2% |
| 净利润同比 | 15.3% | 46.8% |
| 每股收益(稀释后) | $0.07 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MIR
QSI
| Q4 25 | $277.4M | $451.0K | ||
| Q3 25 | $223.1M | $552.0K | ||
| Q2 25 | $222.9M | $591.0K | ||
| Q1 25 | $202.0M | $842.0K | ||
| Q4 24 | $254.3M | $1.2M | ||
| Q3 24 | $206.8M | $787.0K | ||
| Q2 24 | $207.1M | $622.0K | ||
| Q1 24 | $192.6M | $457.0K |
净利润
MIR
QSI
| Q4 25 | $17.3M | $-17.6M | ||
| Q3 25 | $2.9M | $-35.7M | ||
| Q2 25 | $8.3M | $-28.8M | ||
| Q1 25 | $300.0K | $-19.2M | ||
| Q4 24 | $15.0M | $-33.1M | ||
| Q3 24 | $-13.6M | $-25.3M | ||
| Q2 24 | $-11.7M | $-23.1M | ||
| Q1 24 | $-25.8M | $-19.5M |
毛利率
MIR
QSI
| Q4 25 | 48.8% | 27.1% | ||
| Q3 25 | 46.8% | 35.1% | ||
| Q2 25 | 46.0% | 59.4% | ||
| Q1 25 | 47.6% | 57.7% | ||
| Q4 24 | 48.1% | 51.2% | ||
| Q3 24 | 44.9% | 46.6% | ||
| Q2 24 | 47.0% | 56.9% | ||
| Q1 24 | 45.2% | 58.9% |
营业利润率
MIR
QSI
| Q4 25 | 9.2% | -4677.2% | ||
| Q3 25 | 3.3% | -7205.3% | ||
| Q2 25 | 4.4% | -5096.4% | ||
| Q1 25 | 4.3% | -2982.4% | ||
| Q4 24 | 11.4% | -2573.6% | ||
| Q3 24 | -0.8% | -3569.0% | ||
| Q2 24 | 1.1% | -4252.6% | ||
| Q1 24 | -2.5% | -5111.6% |
净利率
MIR
QSI
| Q4 25 | 6.2% | -3904.9% | ||
| Q3 25 | 1.3% | -6467.9% | ||
| Q2 25 | 3.7% | -4879.2% | ||
| Q1 25 | 0.1% | -2279.0% | ||
| Q4 24 | 5.9% | -2778.6% | ||
| Q3 24 | -6.6% | -3216.4% | ||
| Q2 24 | -5.6% | -3713.7% | ||
| Q1 24 | -13.4% | -4261.3% |
每股收益(稀释后)
MIR
QSI
| Q4 25 | $0.07 | $-0.07 | ||
| Q3 25 | $0.01 | $-0.17 | ||
| Q2 25 | $0.03 | $-0.16 | ||
| Q1 25 | $0.00 | $-0.11 | ||
| Q4 24 | $0.08 | $-0.23 | ||
| Q3 24 | $-0.07 | $-0.18 | ||
| Q2 24 | $-0.06 | $-0.16 | ||
| Q1 24 | $-0.13 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $412.3M | $21.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $220.2M |
| 总资产 | $3.6B | $245.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
MIR
QSI
| Q4 25 | $412.3M | $21.6M | ||
| Q3 25 | $933.2M | $30.9M | ||
| Q2 25 | $262.6M | $22.2M | ||
| Q1 25 | $185.8M | $37.3M | ||
| Q4 24 | $175.2M | $49.2M | ||
| Q3 24 | $133.3M | $42.3M | ||
| Q2 24 | $122.2M | $59.6M | ||
| Q1 24 | $120.2M | $53.2M |
总债务
MIR
QSI
| Q4 25 | — | — | ||
| Q3 25 | $444.8M | — | ||
| Q2 25 | $444.9M | — | ||
| Q1 25 | $686.6M | — | ||
| Q4 24 | $686.4M | — | ||
| Q3 24 | $685.1M | — | ||
| Q2 24 | $684.1M | — | ||
| Q1 24 | $685.5M | — |
股东权益
MIR
QSI
| Q4 25 | $1.9B | $220.2M | ||
| Q3 25 | $1.8B | $235.2M | ||
| Q2 25 | $1.5B | $221.0M | ||
| Q1 25 | $1.5B | $246.9M | ||
| Q4 24 | $1.5B | $215.4M | ||
| Q3 24 | $1.5B | $210.5M | ||
| Q2 24 | $1.5B | $233.3M | ||
| Q1 24 | $1.5B | $253.8M |
总资产
MIR
QSI
| Q4 25 | $3.6B | $245.6M | ||
| Q3 25 | $3.5B | $260.1M | ||
| Q2 25 | $2.7B | $254.4M | ||
| Q1 25 | $2.6B | $271.2M | ||
| Q4 24 | $2.6B | $247.9M | ||
| Q3 24 | $2.7B | $236.5M | ||
| Q2 24 | $2.6B | $256.7M | ||
| Q1 24 | $2.6B | $275.6M |
负债/权益比
MIR
QSI
| Q4 25 | — | — | ||
| Q3 25 | 0.24× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.47× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $73.0M | $-16.3M |
| 自由现金流经营现金流 - 资本支出 | $63.2M | $-16.4M |
| 自由现金流率自由现金流/营收 | 22.8% | -3628.4% |
| 资本支出强度资本支出/营收 | 3.5% | 3.8% |
| 现金转化率经营现金流/净利润 | 4.22× | — |
| 过去12个月自由现金流最近4个季度 | $106.9M | $-97.3M |
8季度趋势,按日历期对齐
经营现金流
MIR
QSI
| Q4 25 | $73.0M | $-16.3M | ||
| Q3 25 | $22.3M | $-32.0M | ||
| Q2 25 | $12.4M | $-20.2M | ||
| Q1 25 | $35.6M | $-26.2M | ||
| Q4 24 | $60.8M | $-22.9M | ||
| Q3 24 | $17.1M | $-23.2M | ||
| Q2 24 | $15.2M | $-18.6M | ||
| Q1 24 | $6.0M | $-23.2M |
自由现金流
MIR
QSI
| Q4 25 | $63.2M | $-16.4M | ||
| Q3 25 | $13.0M | $-32.9M | ||
| Q2 25 | $3.6M | $-20.5M | ||
| Q1 25 | $27.1M | $-27.5M | ||
| Q4 24 | $49.1M | $-24.3M | ||
| Q3 24 | $3.9M | $-24.1M | ||
| Q2 24 | $4.1M | $-19.7M | ||
| Q1 24 | $-6.8M | $-24.3M |
自由现金流率
MIR
QSI
| Q4 25 | 22.8% | -3628.4% | ||
| Q3 25 | 5.8% | -5963.6% | ||
| Q2 25 | 1.6% | -3472.8% | ||
| Q1 25 | 13.4% | -3261.4% | ||
| Q4 24 | 19.3% | -2039.9% | ||
| Q3 24 | 1.9% | -3065.8% | ||
| Q2 24 | 2.0% | -3164.0% | ||
| Q1 24 | -3.5% | -5307.2% |
资本支出强度
MIR
QSI
| Q4 25 | 3.5% | 3.8% | ||
| Q3 25 | 4.2% | 163.0% | ||
| Q2 25 | 3.9% | 55.3% | ||
| Q1 25 | 4.2% | 155.2% | ||
| Q4 24 | 4.6% | 120.4% | ||
| Q3 24 | 6.4% | 123.9% | ||
| Q2 24 | 5.4% | 181.2% | ||
| Q1 24 | 6.6% | 228.9% |
现金转化率
MIR
QSI
| Q4 25 | 4.22× | — | ||
| Q3 25 | 7.69× | — | ||
| Q2 25 | 1.49× | — | ||
| Q1 25 | 118.67× | — | ||
| Q4 24 | 4.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIR
| Transferred Over Time | $96.6M | 35% |
| Services | $65.0M | 23% |
| Cancer Care | $61.8M | 22% |
| Labs And Research | $34.0M | 12% |
| Other Care | $20.7M | 7% |
QSI
暂无分部数据